INVST’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-8,661
Closed -$517K – 189
2021
Q3
$517K Buy
8,661
+340
+4% +$21.4K 0.08% 106
2021
Q2
$527K Buy
8,321
+1,214
+17% +$80.9K 0.09% 104
2021
Q1
$480K Buy
7,107
+506
+8% +$33K 0.08% 109
2020
Q4
$434K Buy
6,601
+1,450
+28% +$85.3K 0.08% 125
2020
Q3
$270K Buy
5,151
+728
+16% +$37.4K 0.06% 133
2020
Q2
$221K Buy
+4,423
New +$239K 0.07% 137

Other funds holding EHC

INVST's EHC Position: Q4 2021 in Review

INVST sold out of Encompass Health (EHC) in Q4 2021, closing a stake of 8,661 shares — an estimated $517K sold.

INVST first reported a position in EHC in Q2 2020 and held it in 6 quarters. The position peaked at $527K in Q2 2021. 409 funds tracked by Wall St. Rank hold EHC as of Q4 2021.

  • INVST reported no remaining Encompass Health position as of Q4 2021 after selling out during the quarter.
  • INVST sold 8,661 Encompass Health shares in Q4 2021, an estimated $517K.
  • INVST first reported a position in Encompass Health in Q2 2020 and held it in 6 quarters.
  • INVST's Encompass Health position peaked at $527K in Q2 2021.
  • 409 funds tracked by Wall St. Rank held Encompass Health as of Q4 2021.

Based on INVST's 13F filing for Q4 2021, filed 25 Feb 2022.